Company profile · free preview

Lycia Therapeutics Inc.

LYCA · NASDAQ · Healthcare · Updated 11/12/2026

Five-year financials

Fiscal year
Revenue
Net income
Diluted EPS
Operating cash flow
Free cash flow
Cash
Total debt

Financials are being prepared.

Want the story behind these numbers? Ask Osiris anything about Lycia Therapeutics Inc.'s filings — free.

Create free account

Lycia Therapeutics Inc. insider buying and selling

Recent open-market trades reported on Form 4. Context only — not a reason to buy or sell.

DateInsiderTypeSharesPrice
2026-11-02Venrock Healthcare Capital Partners III, L.P.Purchase8,305$26.95
2026-10-30Venrock Healthcare Capital Partners III, L.P.Purchase200$26.86
2026-10-30Venrock Healthcare Capital Partners III, L.P.Purchase8,804$26.27
2026-10-29Venrock Healthcare Capital Partners III, L.P.Purchase1,000$26.33
2026-10-28Venrock Healthcare Capital Partners III, L.P.Purchase4,430$25.97
2026-10-28Venrock Healthcare Capital Partners III, L.P.Purchase10,570$25.23
2026-10-27Venrock Healthcare Capital Partners III, L.P.Purchase31,067$26.84
2026-10-27Venrock Healthcare Capital Partners III, L.P.Purchase8,729$25.84

SEC filings

Ask anything about Lycia Therapeutics Inc.'s filings

"What changed since last year?" "Where is the cash going?" Get answers drawn straight from the filings.

Start researching free

Compare LYCA head-to-head

More Healthcare companies